Första AP-fonden’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.49M | Sell |
121,300
-900
| -0.7% | -$70.4K | 0.06% | 259 |
|
|
2025
Q1 | $8.86M | Sell |
122,200
-7,900
| -6% | -$573K | 0.07% | 261 |
|
|
2024
Q4 | $9.63M | Sell |
130,100
-3,900
| -3% | -$289K | 0.07% | 266 |
|
|
2024
Q3 | $8.84M | Buy |
134,000
+14,400
| +12% | +$950K | 0.07% | 287 |
|
|
2024
Q2 | $11M | Sell |
119,600
-26,500
| -18% | -$2.45M | 0.1% | 197 |
|
|
2024
Q1 | $14M | Buy |
146,100
+12,600
| +9% | +$1.2M | 0.12% | 172 |
|
|
2023
Q4 | $10.2M | Buy |
133,500
+14,700
| +12% | +$1.12M | 0.1% | 204 |
|
|
2023
Q3 | $8.23M | Hold |
118,800
| – | – | 0.09% | 232 |
|
|
2023
Q2 | $11.2M | Sell |
118,800
-6,100
| -5% | -$575K | 0.12% | 173 |
|
|
2023
Q1 | $10.3M | Sell |
124,900
-26,400
| -17% | -$2.18M | 0.12% | 180 |
|
|
2022
Q4 | $11.3M | Sell |
151,300
-31,800
| -17% | -$2.37M | 0.13% | 178 |
|
|
2022
Q3 | $15.1M | Buy |
183,100
+300
| +0.2% | +$24.8K | 0.19% | 112 |
|
|
2022
Q2 | $17.4M | Sell |
182,800
-2,700
| -1% | -$257K | 0.23% | 93 |
|
|
2022
Q1 | $21.8M | Buy |
185,500
+22,900
| +14% | +$2.7M | 0.25% | 76 |
|
|
2021
Q4 | $21.1M | Buy |
162,600
+14,100
| +9% | +$1.83M | 0.21% | 91 |
|
|
2021
Q3 | $16.8M | Sell |
148,500
-12,000
| -7% | -$1.36M | 0.19% | 110 |
|
|
2021
Q2 | $16.6M | Buy |
160,500
+26,200
| +20% | +$2.71M | 0.2% | 108 |
|
|
2021
Q1 | $11.2M | Buy |
134,300
+9,000
| +7% | +$753K | 0.16% | 147 |
|
|
2020
Q4 | $11.4M | Buy |
125,300
+17,900
| +17% | +$1.63M | 0.17% | 130 |
|
|
2020
Q3 | $8.57M | Buy |
107,400
+22,300
| +26% | +$1.78M | 0.18% | 124 |
|
|
2020
Q2 | $5.88M | Buy |
85,100
+14,300
| +20% | +$988K | 0.15% | 173 |
|
|
2020
Q1 | $4.45M | Buy |
+70,800
| New | +$4.45M | 0.16% | 172 |
|